Healthcare Industry News: radiosurgery
News Release - May 27, 2009
The Ottawa Hospital and Elekta Forge Long-Term Strategic Partnership AgreementAgreement to create world class cancer management centre of excellence harnessing state-of-the-art Elekta technologies
OTTAWA, May 27 -- (Healthcare Sales & Marketing Network) -- Elekta and The Ottawa Hospital (Ottawa, Ontario) have embarked on a decade-long mutual support project that will create an advanced cancer treatment centre. Part of The Ottawa Hospital, The Ottawa Hospital Cancer Centre (TOHCC), will be equipped with radiation therapy systems, as well as workflow enhancing software and treatment planning systems, enabling TOHCC to provide sophisticated therapeutic services in a chartless, paperless clinical environment.
Among the largest Canadian cancer centres, TOHCC has undergone extraordinary growth in its cancer management capacity over the last decade, and steadily has increased its complement of Elekta radiation treatment systems during that period. Its latest expansion to a new site at Queensway Carleton Hospital presented the hospital with an opportunity to evolve into a national/North American leader with global potential.
"We needed to identify a provider with whom we could partner for long-term sustainability and future innovation in radiation therapy," said Greg Doiron, TOHCC Clinical Director. "We determined Elekta was best positioned to move us into our next development phase and help us achieve our long-term objectives, in addition to our short-term need, which is improving patients' access to healthcare."
Under the partnership agreement, The Ottawa Hospital will acquire four Elekta Synergy(R) treatment systems, two to be sited at The Ottawa Hospital's General Campus and two to be operated at Queensway Carleton Hospital site, when the cancer program starts in late 2009.
"Our goal is to use the Elekta Synergy systems to perform advanced methods, such as Image Guided Radiation Therapy (IGRT) and Intensity Modulated Radiation Therapy (IMRT) as soon as possible in appropriate cases," Doiron said.
The Cancer Centre also will acquire MOSAIQ(R) software solutions. MOSAIQ RO will manage radiation therapy simulation, planning, setup, verification, delivery, review and analysis. Integrated with MOSAIQ RO is the MOSAIQ image-enabled electronic medical record (EMR), which supports the cancer care team by uniting diverse systems and devices. These products will form the complete information technology infrastructure to streamline the TOHCC's growing radiation oncology service.
Ottawa harnesses STRATEGIQ(TM) consultative services
The Ottawa Hospital's substantial equipment acquisitions are fundamental to the partnership agreement, but they are not the linchpin to TOHCC's success, Doiron said. To maximize TOHCC's clinical and operational value, The Ottawa Hospital subjected their existing centre to an intensive process review and restructuring through STRATEGIQ(TM) consultative tools and services.
Several Elekta representatives went to The Ottawa Hospital beginning in late 2008 and started the initial process review that carried on into early 2009.
"They mapped our processes in detail," he explained. "The analysis covered everything from patient referral to the cancer centre, the patients' care and their discharge. Everything was documented in a process flow. This allowed Elekta staff to identify business and clinical practices that we could improve and also helped us prioritize what we needed to successfully launch and operate the Queensway Carleton site's service."
TOHCC experience will spur Elekta technology development
The Elekta-TOHCC partnership agreement will provide Elekta with a wealth of clinical data on the performance and effectiveness of its technology, with the aim of using this experience and knowledge to make Elekta's offerings more effective and efficient.
"Combining our technological and clinical resources in The Ottawa Hospital-Elekta partnership agreement is far more than a business transaction," said Gerry Hogue, Vice President and General Manager, Elekta Canada. "This agreement represents the formation of a major, collaborative strategic relationship that we predict will not only benefit the respective partners long into the future, but also will greatly increase access to and increase the quality of cancer management for thousands of patients."
About The Ottawa Hospital Regional Cancer Centre
TOHCC (formerly the Ottawa Regional Cancer Centre) is a cancer treatment and research facility providing cancer services to patients in Ottawa and Eastern Ontario. It is part of The Ottawa Hospital, which serves the healthcare needs of the 1.2 million residents of Ottawa and Eastern Ontario and is one of the largest teaching and research facilities in Canada.
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy and radiosurgery, as well as workflow enhancing software systems across the spectrum of cancer care.
Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives, making the future possible today.
Today, Elekta solutions in oncology and neurosurgery are used in over 5,000 hospitals globally, and every day more than 100,000 patients receive diagnosis, treatment or follow-up with the help of a solution from the Elekta Group.
Elekta employs around 2,500 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. For more information about Elekta, please visit www.elekta.com.
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.